The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
ribociclib · Powder
1 marketed package NDCs · 1 active manufacturer
Most dispensed: SUCCINATE 200 mg · Tablet, Film Coated · #3 blister packs/carton / 14 tablet, film coated in 1 blister pack · SUCCINATE 200 mg · Tablet, Film Coated · #3 blister packs/carton / 21 tablet, film coated in 1 blister pack
Same drug class
Other molecules FDA puts in Kinase Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Ribociclib in shortage right now?
- No. FDA does not currently list Ribociclib in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Ribociclib?
- 1 company has marketed Ribociclib in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
- What does Ribociclib cost?
- The typical pharmacy pays about $318.33 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.